Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Vaccines

Business & Regulation COVID-19

From COVID-19 to Monkeypox

| Stephanie Sutton

It’s been a busy time for infectious disease vaccine news in Europe.

Manufacture Vaccines

The mRNA Manufacturing Advantage

| Natraj Ram

With mRNA offering more straightforward development and manufacturing processes, are the days of traditional vaccine modalities numbered?

Business & Regulation Trends & Forecasts

How COVID-19 Saved Pfizer’s Revenue

| Stephanie Sutton | 3 min read

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

Business & Regulation COVID-19

A Tale of Two Continents

| Stavros Nicolaou

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

Manufacture Vaccines

Taking the mRNA Highway from Development to Commercialization

| Serena Fries Smith

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Manufacture Vaccines

The ABCs of mRNA: Download Our eBook

Our eBook features mRNA vs malaria, vaccines, top tips for mRNA sequencing, and more

Business & Regulation Packaging

Desert, Tundra, and Archipelago: a Vaccine Epic

What did the industry learn about logistics during COVID vaccine rollout, and how will it make sure nobody gets left behind?

Discovery & Development Drug Delivery

Cupping Combats COVID-19?

| Angus Stewart

A technique comparable to the alternative medicinal practice of “cupping” has shown potential in improving delivery of nucleic acid medicines.

Business & Regulation Advanced Medicine

2021 in Review: Our Best Videos

| Angus Stewart

Panels, thought leaders, and spicy opinions! Here’s a roundup of our best video content of 2021.

Manufacture Bioprocessing - Upstream & Downstream

Keep Calm and Use Pools

| Trent Munro

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.


Latest White Papers

Total virus titer in minutes

| Contributed by Malvern Panalytical

Measurement of the concentration of Adeno-Associated Virus

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register